Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
United Therapeutics Corp (UTHR)  
$272.88 3.62 (1.31%) as of 4:30 Fri 5/24


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 47,262,000
Market Cap: 12.90(B)
Last Volume: 408,164 Avg Vol: 421,328
52 Week Range: $205.19 - $276.5
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Other

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   United Therapeutics is a biotechnology company. Through its subsidiary, Lung Biotechnology PBC, Co. is focused on addressing the acute national shortage of transplantable lungs and other organs with a variety of technologies that either delay the need for such organs or expand the supply. Co. markets and sells the following commercial therapies to treat pulmonary arterial hypertension: Remodulin® (treprostinil) Injection; Tyvaso® (treprostinil) Inhalation Solution; Orenitram® (treprostinil) Extended-Release Tablets; and Adcirca® (tadalafil) Tablets. In the U.S., Co. also markets and sells an oncology product, Unituxin® (dinutuximab) Injection, for the treatment of high-risk neuroblastoma.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 577,395 619,080 681,963 1,862,458
Total Sell Value $140,716,560 $150,163,103 $164,291,315 $457,286,236
Total People Sold 8 8 8 11
Total Sell Transactions 69 79 91 266
End Date 2024-02-25 2023-11-24 2023-05-26 2022-05-26

   
Records found: 5052
  Page 28 of 203  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Rothblatt Martine A Chairperson & CEO   •       •      –    2021-12-20 4 AS $200.00 $616,400 D/D (3,082) 130 -12%     
   Rothblatt Martine A Chairperson & CEO   •       •      –    2021-12-20 4 OE $53.42 $164,640 D/D 3,082 3,212     -
   Mahon Paul A EVP & General Counsel   •       •      –    2021-12-16 4 AS $194.21 $1,173,171 D/D (6,000) 36,369 -8%     
   Mahon Paul A EVP & General Counsel   •       •      –    2021-12-16 4 OE $111.00 $666,000 D/D 6,000 42,369     -
   Benkowitz Michael President and COO   •       •      –    2021-12-16 4 D $195.86 $783,440 D/D (4,000) 2,235     -
   Benkowitz Michael President and COO   •       •      –    2021-12-16 4 OE $61.06 $244,240 D/D 4,000 6,235     -
   Benkowitz Michael President and COO   •       •      –    2021-12-14 4 D $193.93 $775,720 D/D (4,000) 2,235     -
   Benkowitz Michael President and COO   •       •      –    2021-12-14 4 OE $61.06 $244,240 D/D 4,000 6,235     -
   Benkowitz Michael President and COO   •       •      –    2021-12-07 4 D $190.41 $761,640 D/D (4,000) 2,235     -
   Benkowitz Michael President and COO   •       •      –    2021-12-07 4 OE $61.06 $244,240 D/D 4,000 6,235     -
   Olian Judy D. Director   –       •      –    2021-11-23 4 GD $0.00 $0 D/D 920 8,230     -
   Benkowitz Michael President and COO   •       –      –    2021-11-23 4 D $201.58 $806,320 D/D (4,000) 2,235     -
   Benkowitz Michael President and COO   •       –      –    2021-11-23 4 OE $61.06 $244,240 D/D 4,000 6,235     -
   Rothblatt Martine A Chairperson & CEO   •       •      –    2021-11-22 4 AS $200.42 $617,895 D/D (3,083) 130 -7%     
   Rothblatt Martine A Chairperson & CEO   •       •      –    2021-11-22 4 OE $53.42 $164,694 D/D 3,083 3,213     -
   Benkowitz Michael President and COO   •       •      –    2021-11-18 4 D $202.61 $810,440 D/D (4,000) 2,235     -
   Benkowitz Michael President and COO   •       •      –    2021-11-18 4 OE $53.83 $215,320 D/D 4,000 6,235     -
   Mahon Paul A EVP & General Counsel   •       •      –    2021-11-18 4 D $197.78 $1,195,957 D/D (6,000) 36,369     -
   Mahon Paul A EVP & General Counsel   •       •      –    2021-11-18 4 OE $111.00 $666,000 D/D 6,000 42,369     -
   Rothblatt Martine A Chairperson & CEO   •       •      –    2021-11-17 4 AS $201.90 $622,458 D/D (3,083) 130 -10%     
   Rothblatt Martine A Chairperson & CEO   •       •      –    2021-11-17 4 OE $53.42 $164,694 D/D 3,083 3,213     -
   Benkowitz Michael President and COO   •       •      –    2021-11-16 4 D $203.24 $812,960 D/D (4,000) 2,235     -
   Benkowitz Michael President and COO   •       •      –    2021-11-16 4 OE $53.83 $215,320 D/D 4,000 6,235     -
   Rothblatt Martine A Chairman & CEO   •       •      –    2021-11-15 4 AS $203.45 $627,236 D/D (3,083) 130 -13%     
   Rothblatt Martine A Chairman & CEO   •       •      –    2021-11-15 4 OE $53.42 $164,694 D/D 3,083 3,213     -
  5052 Records found
  Previous  20  21  22  23  24  25  26  27  28  29  Next   
  Page 28 of 203
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us